Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial Randomized, Placebo-controlled, Using Dapsone as a Neuroprotector During Acute Ischemia Stroke

NCT01144650 is registered in ClinicalTrials.gov with Cidat, S.A. de C.V. as lead sponsor.

NCT NCT01144650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01144650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial Randomized, Placebo-controlled, Using Dapsone as a Neuroprotector During Acute Ischemia Stroke
Lead sponsor
Cidat, S.A. de C.V.
Phase
Phase 2/3
Overall status
Unknown status
Start date
July 31, 2009
Completion date
November 30, 2010
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral stroke, cerebrovascular accident, acute, cerebrovascular stroke, stroke, stroke, acute